Gingival Recession – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Gingival Recession Market Outlook

Thelansis’s “Gingival Recession Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Gingival Recession treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Gingival Recession Overview

Gingival recession, also known as soft tissue recession, is characterized by the displacement of the gingival margin below the cementoenamel junction (CEJ) of a tooth or the platform of a dental implant. This condition involves the loss of various periodontal tissues, including gingiva, periodontal ligament, root cementum, and bone at dental sites, and the loss of mucosa and bone around dental implants. The underlying causes of gingival recession encompass a range of factors, such as inflammatory periodontal diseases, trauma resulting from aggressive oral hygiene practices, recurrent inflammation due to bone dehiscence or fenestration beneath the gingiva, repeated inflammation linked to poorly fitting dental restorations, orthodontic-induced tooth movement through the labial bone plate, viral-induced ulceration of the gingival margin, cytotoxic drug-induced ulceration, benign familial neutropenia, traumatic injuries to the gingival margin, and compromised blood supply to the gingiva. Signs and symptoms that may indicate the presence of gingival recession include tooth mobility heightened tooth sensitivity characterized by short and intense pain, apparent elongation of teeth due to receding gums, visible exposure of tooth roots, formation of notches at the gum line of affected teeth, alterations in tooth color attributed to the differing shades between enamel and cementum, perception of increased spacing between teeth due to reduced gum coverage, and occurrence of cavities beneath the gum line. Additionally, gingival recession elevates the susceptibility to root surface caries development. Gingival recession is also commonly observed in pediatric populations. Several factors contribute to the predisposition of patients to developing gingival recession, including the presence of a narrow band of attached or keratinized gingiva, alveolar bony dehiscence, trauma from toothbrushing, prominent teeth, constraining frenum attachment, soft tissue interference from opposing occlusion, orthodontic tooth movement, utilization of impression techniques involving subgingival tissue retraction, oral habits, periodontitis, pseudo recession (extrusion of teeth), and intraoral piercings like tongue piercings. Numerous classification systems have been introduced to categorize gingival recession. Miller's classification system is the most widely adopted. Nevertheless, many cases cannot be effectively categorized based on the criteria of standard classification systems. An alternative classification system proposed by Kumar & Masamatti offers a comprehensive representation of recession defects and accommodates cases that cannot be classified using existing systems. Predominantly employed methods for treating gingival recession defects encompass pedicle flap surgical techniques, such as coronally advanced or rotational flaps.

• It was estimated that over 20 million individuals in the United States are affected by this condition.

Geography Covered:

North America- the United States and Canada

Europe- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

Other countries- Japan & China

Study Period: 2022-2032

Current Clinical Practice and Treatment Algorithm

This section of the study covers country-specific current clinical practice, the standard of care, and significant limitations around addressing the unmet needs. Retrospective analysis and bench-marking of clinical study outcomes are presented in terms of Pre-treatment & post-treatment clinical and demographic patient characteristics. Essentially, this section will cover the evolution of the current competitive landscape and its impact on the future treatment paradigm.

KOL Insights:

KOLs across 8 MM markets from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs

Market Forecast: Patient Based Forecast Model (MS. Excel Based Automated Dashboard)

- Data Inputs with sourcing

- Market Event and Product Event

- Country-specific Forecast Model

- Market uptake and patient share uptake

- Attribute Analysis

- Analog Analysis

- Disease burden and pricing scenario

- Summary and Insights

NPV/ IRR Calculator-

Optimization of cash flow/ revenue flow concerning all fixed and variable investments throughout the product development process. The rate of return on an investment is a critical indicator to ensure the profitability and break-even of the project.

Competitive Landscape:

The competitive landscape includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review such as Orphan drug designation, Fast track, Priority Review, Breakthrough Therapy Designation, Rare Pediatric Disease Designation, and Accelerated Approval are tracked and supplemented with analyst commentary.

Clinical Trial Assessment-

Detailed clinical trial data analysis and critical product positioning include trial design, primary outcomes, secondary outcomes, dosing and schedules, inclusion and exclusion criteria, recruitment status and essentially covers the reported adverse events. Majorly the trial analysis helps determine the potential of the critical assets and their probable filing and launch date.

Unmet Medical Needs Overview-

This report presents the most important clinical unmet needs in the treatment, according to Thelansis research and analysis. Other essential unmet needs identified through our study include decreased cost burden on patients, improved administration convenience, and improved patient compliance.

Visit our social media pages: